株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

嚢胞性線維症治療薬の世界市場の分析:薬剤クラス・投与経路・地域別の将来予測

Global Cystic Fibrosis Therapeutics Market Size study, by Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), by Route of administration (Oral Drugs, Inhaled Drugs) and Regional Forecasts 2018-2025

発行 Bizwit Research & Consulting LLP 商品コード 745567
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
嚢胞性線維症治療薬の世界市場の分析:薬剤クラス・投与経路・地域別の将来予測 Global Cystic Fibrosis Therapeutics Market Size study, by Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), by Route of administration (Oral Drugs, Inhaled Drugs) and Regional Forecasts 2018-2025
出版日: 2018年11月13日 ページ情報: 英文
概要

当レポートでは、世界の嚢胞性線維症むけ治療薬の市場について分析し、市場の基本構造 (バリューチェーンなど) や主な促進・抑制要因、全体的な市場規模の動向見通し (過去3年間・今後8年間分)、薬剤クラス別・投与経路別および地域別の詳細動向、主要企業のプロファイル・市場シェアといった情報を取りまとめてお届けいたします。

第1章 エグゼクティブ・サマリー

第2章 嚢胞性線維症治療薬市場:定義と範囲

第3章 嚢胞性線維症治療薬市場のダイナミクス

  • シーソー分析
    • 市場促進要因
    • 市場抑制要因
    • 市場機会

第4章 嚢胞性線維症治療薬市場:産業分析

  • ポーターのファイブフォース分析
  • PEST分析
    • 政治的・経済的・社会的・技術的シナリオ
  • バリューチェーン分析
    • サプライヤー
    • メーカー/サービスプロバイダー
    • 流通業者
    • エンドユーザー
  • 主な購入基準
  • 規制枠組み
  • コスト構造の分析
    • 原材料費の分析
    • 製造費用の分析
    • 人件費の分析
  • 投資/導入シナリオ
  • アナリストの提言、結論

第5章 嚢胞性線維症治療薬市場:薬剤クラス別

  • 市場の現状
  • 市場の実績:潜在的なモデル
  • 主要企業
  • 薬剤クラス別の市場分析
    • 膵酵素サプリメント
    • 粘液溶解薬
    • 気管支拡張剤
    • CFTR (嚢胞性線維症膜コンダクタンス制御因子) 調整剤

第6章 嚢胞性線維症治療薬市場:投与経路別

  • 市場の現状
  • 市場の実績:潜在的なモデル
  • 主要企業
  • 投与経路別の市場分析
    • 経口薬
    • 吸入薬

第7章 嚢胞性線維症治療薬市場:地域別

  • 嚢胞性線維症治療薬市場:地域別の概況 (通算11年間分)
  • 北米市場 (米国、カナダ)
    • 市場規模の推計値・予測値 (金額ベース、今後11年間分)
    • 市場規模の推計値・予測値:薬剤クラス別 (金額ベース、今後11年間分)
    • 市場規模の推計値・予測値:投与経路別 (金額ベース、今後11年間分)
  • 欧州市場 (英国、ドイツ、フランスなど)
  • アジア市場 (中国、インド、日本など)
  • ラテンアメリカ市場 (ブラジル、メキシコ)
  • 他の国々の市場 (RoW:南米、中東・アフリカ)

第8章 企業情報

  • 企業別市場シェア
  • 大手企業の戦略
  • 企業プロファイル
    • Abbvie
      • 概要
      • 財務指標
      • 製品の概要
      • 近年の動向
    • F. Hoffmann-La Roche Ltd.
    • Gilead
    • Vertex Pharmaceuticals Inc.
    • Alaxia

第9章 分析過程

図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF CYSTIC FIBROSIS THERAPEUTICS
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF CYSTIC FIBROSIS THERAPEUTICS
  • TABLE 3. CYSTIC FIBROSIS THERAPEUTICS, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. CYSTIC FIBROSIS THERAPEUTICS ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. CYSTIC FIBROSIS THERAPEUTICS ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. CYSTIC FIBROSIS THERAPEUTICS ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
  • TABLE 9. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. CYSTIC FIBROSIS THERAPEUTICS BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW CYSTIC FIBROSIS THERAPEUTICSMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. CYSTIC FIBROSIS THERAPEUTICS, RESEARCH METHODOLOGY
  • FIG 2. CYSTIC FIBROSIS THERAPEUTICS, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. CYSTIC FIBROSIS THERAPEUTICS, KEY TRENDS 2016
  • FIG 5. CYSTIC FIBROSIS THERAPEUTICS, GROWTH PROSPECTS 2017-2025
  • FIG 6. CYSTIC FIBROSIS THERAPEUTICS, PORTERS 5 FORCE MODEL
  • FIG 7. CYSTIC FIBROSIS THERAPEUTICS, PEST ANALYSIS
  • FIG 8. CYSTIC FIBROSIS THERAPEUTICS, VALUE CHAIN ANALYSIS
  • FIG 9. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. CYSTIC FIBROSIS THERAPEUTICS BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. CYSTIC FIBROSIS THERAPEUTICS, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA CYSTIC FIBROSIS THERAPEUTICSMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE CYSTIC FIBROSIS THERAPEUTICSMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC CYSTIC FIBROSIS THERAPEUTICSMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA CYSTIC FIBROSIS THERAPEUTICSMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. CYSTIC FIBROSIS THERAPEUTICS, COMPANY MARKET SHARE ANALYSIS (2016)
目次

Global Cystic Fibrosis Therapeutics Market to reach USD XX billion by 2025.

Global Cystic Fibrosis Therapeutics Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major driving factor of global cystic fibrosis therapeutics market are rising prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, technological advancement and high rate of Research & Development initiatives. The growing strategic collaboration is one of the key trends contributing towards the growth of the cystic fibrosis (CF) therapeutics market. The major restraining factors of the global cystic fibrosis therapeutics market are high cost related to the treatment, drug discontinuation and increase in complexity of disease. In addition, patent expiries from many companies and introduction of generic drugs is expected to restrain the growth of cystic fibrosis therapeutics market. The Cystic Fibrosis Therapeutics market is on the surging trend considering the global scenario. The Cystic fibrosis refers to an inherited disease which impacts the secretory glands of an individual's body such as Pancreas, lungs, liver and intestines. Cystic fibrosis transmembrane conductance regulator (CFTR) is synthesized in the rough endoplasmic reticulum (RER) followed by glycosylation in the Golgi apparatus and performing the function of a Cl- channel, and regulator of other ion channels when located in the plasma membrane. Cystic fibrosis leads to abnormal secretions that lead to mucus buildup which result in no proper working of an affected organ. Treatment of cystic fibrosis includes a physical therapy, which helps in loosening of mucus and use of medications and enzymes to fight against infections in an organ. Cystic fibrosis is caused due to mutation in gene that is required for protein CFTR.

The regional analysis of Global Cystic Fibrosis Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounted leading share of total generating revenue in 2017 across the globe due to large number of aging population and high technological awareness and advancement. Asia-Pacific region region is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025. China and India are expected to be the fastest growing cystic fibrosis markets in Asia-Pacific due to emerging countries are large pool of patients, rising government funding and increasing Research & Development investment.

The major market player included in this report are:

  • Abbvie
  • F. Hoffmann-La Roche Ltd.
  • Gilead
  • Vertex Pharmaceuticals Inc.
  • Alaxia

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Class:

  • Pancreatic Enzyme Supplements
  • Mucolytic
  • Bronchodilators
  • CFTR Modulators

By Route of administration:

  • Oral Drugs
  • Inhaled Drugs

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2015, 2016
  • Base year - 2017
  • Forecast period - 2018 to 2025

Target Audience of the Global Cystic Fibrosis Therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Cystic Fibrosis Therapeutics, by Class, 2015-2025 (USD Billion)
    • 1.3.2. Cystic Fibrosis Therapeutics, by Route of administration, 2015-2025 (USD Billion)
    • 1.3.3. Cystic Fibrosis Therapeutics, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Cystic Fibrosis Therapeutics Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Cystic Fibrosis Therapeutics Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Cystic Fibrosis Therapeutics Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Users
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labour Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Cystic Fibrosis Therapeutics, by Class

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Cystic Fibrosis Therapeutics, Sub Segment Analysis
    • 5.4.1. Pancreatic Enzyme Supplements
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. Mucolytic
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.3. Bronchodilators
      • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.4. CFTR Modulators
      • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Cystic Fibrosis Therapeutics, by Route of administration

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Cystic Fibrosis Therapeutics, Sub Segment Analysis
    • 6.4.1. Oral Drugs
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Inhaled Drugs
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Cystic Fibrosis Therapeutics, by Regional Analysis

  • 7.1. Cystic Fibrosis Therapeutics, Regional Market Snapshot (2015-2025)
  • 7.2. North America Cystic Fibrosis Therapeutics Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.3. Europe Cystic Fibrosis Therapeutics Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.3. France
      • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.3.4. Rest of Europe
      • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.4. Asia Cystic Fibrosis Therapeutics Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.5. Latin America Cystic Fibrosis Therapeutics Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Abbvie
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. F. Hoffmann-La Roche Ltd.
    • 8.3.3. Gilead
    • 8.3.4. Vertex Pharmaceuticals Inc.
    • 8.3.5. Alaxia

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top